Camber Pharma Launches Generic Protonix®
Piscataway, NJ, January 22, 2015– Camber Pharmaceuticals announces that it has launched Pantoprazole Sodium Delayed-Release Tablets USP. The drug is the generic version of Protonix® tablets. Pantoprazole is used to treat gastro esophageal reflux disease, (GERD) and damage to the esophagus.
Pantoprazole is available from Camber in 20 and 40mg’s and comes in 90 count bottles.
If you would like more information about this topic, please contact Megan Becker at 732.529.0436 or email at [email protected].
Recent articles
- Camber Launches Temozolomide Capsules, USP
- Camber Launches Eltrombopag Tablets & Oral Suspension
- Camber Launches Eslicarbazepine Acetate Tablets
- Camber Launches Phenylephrine Hydrochloride Injection, USP
- Camber Launches Chlorzoxazone Tablets, USP
- Camber Launches 13 New Generic Products in Q1 2025, Sets Ambitious Pace for the Year